October 3rd, 2018New types of combined oral contraceptives (containing both lower doses of oestrogens and newer progestogens) are associated with a reduced risk of ovarian cancer, in...
July 18th, 2018Johnson & Johnson, which is battling 9,000 legal cases involving its signature baby powder, has been ordered to pay $4.7bn in damages to 22 women who alleged that...
A Missouri Appeals Court has thrown out a $55m verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using...
April 11th, 2018Johnson & Johnson has suffered its first trial loss in a lawsuit claiming its talc-based products including Johnson’s Baby Powder contain cancer-causing asbestos,...
A pill which has the potential to buy an extra 16 months of life for women with ovarian cancer has been dubbed a “milestone” treatment, after it was licensed for use...Weekly Roundup
A European Medicines Agency (EMA) panel has recommended the approval of Tesaro Inc’s key drug, niraparib, for the treatment of recurrent ovarian cancer, reports...Medico-Legal
A jury has ordered Johnson & Johnson (J&J) to pay $417m to a woman who claimed she developed ovarian cancer after using the company’s talc-based products such...Medico-Legal
Johnson & Johnson is seizing upon a recent US Supreme Court ruling limiting where injury lawsuits can be filed, to fight off claims it failed to warn women that...Oncology
A new targeted treatment for ovarian cancer has shown 'very promising' results in women in the advanced stages of the disease, shrinking tumours in around half of women...
March 1st, 2017A blood test every four months could help women at high-risk of ovarian cancer find tumours early, found a UK study.
There is currently no screening programme for the...
